Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Craig

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Intra-tumoral epigenetic heterogeneity and aberrant molecular clocks in hepatocellular carcinomaPaula Restrepo, Adrian Bubie, Amanda J Craig, et al.
Hepatology Communications|June 18, 2021
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNAIsmail Labgaa, Johann von Felden, Amanda J Craig, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Translational Stroke Research|July 18, 2023
TRPC Channels Activated by G Protein-Coupled Receptors Drive Ca<sup>2+</sup> Dysregulation Leading to Secondary Brain Injury in the Mouse ModelJasneet Parmar, Georg von Jonquieres, Nagarajesh Gorlamandala, et al.
Carcinogenesis|February 17, 2024
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolismYuuki Ohara, Amanda J Craig, Huaitian Liu, et al.
International Journal of Cancer|April 17, 2024
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancerYuuki Ohara, Huaitian Liu, Amanda J Craig, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerPaloma Moreno, Yuuki Ohara, Amanda J Craig, et al.
Carcinogenesis|August 13, 2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerPaloma Moreno, Yuuki Ohara, Amanda J Craig, et al.
Histopathology|January 13, 2019
A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sitesSebastiao N Martins-Filho, Venancio A F Alves, Alda Wakamatsu, et al.
American Journal of Veterinary Research|October 31, 2012
Comparison of pharmacokinetic variables for creatinine and iohexol in dogs with various degrees of renal functionCécile M Collignon, Reidun Heiene, Yann Queau, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Intra-tumoral epigenetic heterogeneity and aberrant molecular clocks in hepatocellular carcinomaPaula Restrepo, Adrian Bubie, Amanda J Craig, et al.
Hepatology Communications|June 18, 2021
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNAIsmail Labgaa, Johann von Felden, Amanda J Craig, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Translational Stroke Research|July 18, 2023
TRPC Channels Activated by G Protein-Coupled Receptors Drive Ca<sup>2+</sup> Dysregulation Leading to Secondary Brain Injury in the Mouse ModelJasneet Parmar, Georg von Jonquieres, Nagarajesh Gorlamandala, et al.
Carcinogenesis|February 17, 2024
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolismYuuki Ohara, Amanda J Craig, Huaitian Liu, et al.
International Journal of Cancer|April 17, 2024
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancerYuuki Ohara, Huaitian Liu, Amanda J Craig, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerPaloma Moreno, Yuuki Ohara, Amanda J Craig, et al.
Carcinogenesis|August 13, 2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerPaloma Moreno, Yuuki Ohara, Amanda J Craig, et al.
Histopathology|January 13, 2019
A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sitesSebastiao N Martins-Filho, Venancio A F Alves, Alda Wakamatsu, et al.
American Journal of Veterinary Research|October 31, 2012
Comparison of pharmacokinetic variables for creatinine and iohexol in dogs with various degrees of renal functionCécile M Collignon, Reidun Heiene, Yann Queau, et al.
Pageof 3